Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery

NCT01791322 is registered in ClinicalTrials.gov with Fore Biotherapeutics as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery
Lead sponsor
Fore Biotherapeutics
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients eligible for tumor biopsy, patients that have been diagnosed with colorectal cancer